The federal government has announced a new 10-year pandemic flu vaccine contract with GlaxoSmithKline, valued at more than $425-million.
The contract is intended to ensure a secure supply of vaccine for Canadians in the event of a future influenza pandemic and reduce the possibility of delays in delivery and distribution.
The vaccine will be made at the company’s facility in Ste-Foy, Que.
And this time around, the government has also signed a three-year contract with Sanofi Pasteur Ltd. of Toronto to provide access to a back-up supply of pandemic vaccine if needed.
That contract is worth just over $33-million and would provide an alternate source of vaccine to treat vulnerable populations, such as pregnant women and those suffering from chronic diseases.